{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:41:43Z","timestamp":1768016503630,"version":"3.49.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ahjo.2025.100702","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:06:59Z","timestamp":1766131619000},"page":"100702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Coronary artery disease and cancer: Shared risk factors, pathogenesis, and treatment effects"],"prefix":"10.1016","volume":"61","author":[{"given":"Nicole","family":"Charbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Aramouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Sater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Kreidieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahjo.2025.100702_bb0005","author":"Organization, W.H"},{"issue":"7","key":"10.1016\/j.ahjo.2025.100702_bb0010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The Effect of Advances in Lung-Cancer Treatment on Population Mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","article-title":"Cardiovascular Risk Factors are Associated with Future Cancer","volume":"3","author":"Lau","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"6s","key":"10.1016\/j.ahjo.2025.100702_bb0020","first-page":"6s8","article-title":"Cancer and thrombosis: new insights to an old problem","volume":"45","author":"Leiva","year":"2020","journal-title":"J Med Vasc"},{"issue":"S01","key":"10.1016\/j.ahjo.2025.100702_bb0025","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.thromres.2022.01.004","article-title":"Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies","volume":"213","author":"Moik","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ahjo.2025.100702_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122377","article-title":"Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management","volume":"338","author":"Jiang","year":"2024","journal-title":"Life Sci."},{"issue":"36","key":"10.1016\/j.ahjo.2025.100702_bb0035","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0040","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ahjo.2025.100702_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012639","article-title":"Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?","volume":"8","author":"Howard","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100702_bb0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","article-title":"Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.ahjo.2025.100702_bb0055","article-title":"Diagnosis, clinical management, and emerging strategies for coronary artery disease in patients with cancer","volume":"56","author":"Charbel","year":"2025","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaccao.2019.08.004","article-title":"Birth and Maturation of Cardio-Oncology","volume":"1","author":"Bhatt","year":"2019","journal-title":"JACC CardioOncol"},{"issue":"48","key":"10.1016\/j.ahjo.2025.100702_bb0065","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1093\/eurheartj\/ehz598","article-title":"Cardiovascular disease following breast cancer treatment: can we predict who will be affected?","volume":"40","author":"Lyon","year":"2019","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0070","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"10203","key":"10.1016\/j.ahjo.2025.100702_bb0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of Arterial Thromboembolism in Patients With Cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"48","key":"10.1016\/j.ahjo.2025.100702_bb0085","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ahjo.2025.100702_bb0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2459\/JCM.0000000000000701","article-title":"Neoplastic disease after acute coronary syndrome: incidence, duration, and features: the ABC-4* Study on Heart Disease","volume":"19","author":"Berton","year":"2018","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MCA.0000000000000429","article-title":"Long-term outcomes after percutaneous coronary interventions in cancer survivors","volume":"28","author":"Landes","year":"2017","journal-title":"Coron. Artery Dis."},{"issue":"7","key":"10.1016\/j.ahjo.2025.100702_bb0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/clc.22007","article-title":"Treatment and outcomes of acute coronary syndrome in the cancer population","volume":"35","author":"Yusuf","year":"2012","journal-title":"Clin. Cardiol."},{"issue":"7","key":"10.1016\/j.ahjo.2025.100702_bb0105","first-page":"631","article-title":"Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy","volume":"7","author":"Iannaccone","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0110","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body Fatness and Cancer--Viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9612","key":"10.1016\/j.ahjo.2025.100702_bb0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ahjo.2025.100702_bb0125","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100702_bb0130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","article-title":"Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women","volume":"63","author":"Sanfilippo","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ahjo.2025.100702_bb0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2407-14-132","article-title":"Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression","volume":"14","author":"Rodrigues Dos Santos","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00423-006-0111-z","article-title":"Cigarette smoking: cancer risks, carcinogens, and mechanisms","volume":"391","author":"Hecht","year":"2006","journal-title":"Langenbeck\u2019s Arch. Surg."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/annonc\/mds337","article-title":"Light alcohol drinking and cancer: a meta-analysis","volume":"24","author":"Bagnardi","year":"2013","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0150","first-page":"816","article-title":"Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA","volume":"176","author":"Moore","year":"2016","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0155","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/dyw319","article-title":"Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies","volume":"46","author":"Aune","year":"2017","journal-title":"Int. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.ahjo.2025.100702_bb0160","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jamainternmed.2019.2806","article-title":"Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality in a Japanese Cohort","volume":"179","author":"Budhathoki","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ahjo.2025.100702_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2020.04.085","article-title":"De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study","volume":"313","author":"Kwak","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ahjo.2025.100702_bb0170","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer - role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ahjo.2025.100702_bb0175","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.ahjo.2025.100702_bb0190","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ahjo.2025.100702_bb0195","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10105","key":"10.1016\/j.ahjo.2025.100702_bb0200","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.ahjo.2025.100702_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000915118","article-title":"Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion","volume":"118","author":"Tengesdal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/cancers13030477","article-title":"Therapeutic Strategies for Targeting IL-1 in Cancer","volume":"13","author":"Gottschlich","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ahjo.2025.100702_bb0220","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ahjo.2025.100702_bb0230","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2019.12.010","article-title":"Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice","volume":"158","author":"Perusina Lanfranca","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0235","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajh.24352","article-title":"Reduction in C-reactive protein indicates successful targeting of the IL-1\/IL-6 axis resulting in improved survival in early stage multiple myeloma","volume":"91","author":"Lust","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100702_bb0240","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jgh.15307","article-title":"Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma","volume":"36","author":"Nguyen","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.ahjo.2025.100702_bb0245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.ahjo.2025.100702_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease","volume":"25","author":"Madamanchi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ahjo.2025.100702_bb0260","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/10715760500539154","article-title":"Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction","volume":"40","author":"Elesber","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2025.100702_bb0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0270","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"16","key":"10.1016\/j.ahjo.2025.100702_bb0275","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ahjo.2025.100702_bb0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2017.06.016","article-title":"Platelet granule release is associated with reactive oxygen species generation during platelet storage: A direct link between platelet pro-inflammatory and oxidation states","volume":"156","author":"Ghasemzadeh","year":"2017","journal-title":"Thromb. Res."},{"issue":"25","key":"10.1016\/j.ahjo.2025.100702_bb0285","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/eurheartj\/ehx146","article-title":"Regulation of oxidized platelet lipidome: implications for coronary artery disease","volume":"38","author":"Chatterjee","year":"2017","journal-title":"Eur. Heart J."},{"issue":"517","key":"10.1016\/j.ahjo.2025.100702_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0481","article-title":"Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis","volume":"11","author":"Barrett","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"21","key":"10.1016\/j.ahjo.2025.100702_bb0295","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.2019000518","article-title":"Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps","volume":"134","author":"Marx","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0300","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1055\/s-0039-1692983","article-title":"Platelet-Neutrophil Crosstalk in Atherothrombosis","volume":"119","author":"Pircher","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.ahjo.2025.100702_bb0305","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/09537104.2020.1810653","article-title":"Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis","volume":"32","author":"Ma","year":"2021","journal-title":"Platelets"},{"issue":"9","key":"10.1016\/j.ahjo.2025.100702_bb0310","first-page":"4295","article-title":"Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis","volume":"17","author":"Zhao","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"21","key":"10.1016\/j.ahjo.2025.100702_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218169","article-title":"Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature","volume":"21","author":"Hufnagel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ahjo.2025.100702_bb0320","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/liv.14560","article-title":"Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma","volume":"40","author":"Liu","year":"2020","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0325","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.13604","article-title":"C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice","volume":"15","author":"Shirai","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0330","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09537104.2018.1453059","article-title":"The pro-inflammatory role of platelets in cancer","volume":"29","author":"Olsson","year":"2018","journal-title":"Platelets"},{"issue":"11","key":"10.1016\/j.ahjo.2025.100702_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0340","doi-asserted-by":"crossref","first-page":"19296","DOI":"10.1038\/s41598-020-76351-4","article-title":"Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors","volume":"10","author":"Zaslavsky","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0345","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ahjo.2025.100702_bb0350","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcvm.2017.00074","article-title":"Platelet-Derived Microvesicles in Cardiovascular Diseases","volume":"4","author":"Zaldivia","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.ahjo.2025.100702_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113215","article-title":"Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma","volume":"12","author":"Hayashi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0360","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaccao.2020.04.009","article-title":"The TICONC (Ticagrelor-Oncology) Study: Implications of P2Y(12) Inhibition for Metastasis and Cancer-Associated Thrombosis","volume":"2","author":"Wright","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"40","key":"10.1016\/j.ahjo.2025.100702_bb0365","doi-asserted-by":"crossref","first-page":"42733","DOI":"10.18632\/oncotarget.5811","article-title":"Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0370","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.hfc.2022.02.010","article-title":"Therapy-Related Clonal Hematopoiesis: A New Link Between Cancer and Cardiovascular Disease","volume":"18","author":"Yura","year":"2022","journal-title":"Heart Fail. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.ahjo.2025.100702_bb0375","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.thromres.2021.12.009","article-title":"Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors","volume":"213","author":"Fuster","year":"2022","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0380","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"6465","key":"10.1016\/j.ahjo.2025.100702_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ahjo.2025.100702_bb0390","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.118.034392","article-title":"CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk","volume":"138","author":"Libby","year":"2018","journal-title":"Circulation"},{"issue":"436","key":"10.1016\/j.ahjo.2025.100702_bb0395","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"26","key":"10.1016\/j.ahjo.2025.100702_bb0400","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"Suppl D","key":"10.1016\/j.ahjo.2025.100702_bb0410","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/eurheartj\/sux019","article-title":"ANMCO\/AIOM\/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary","volume":"19","author":"Tarantini","year":"2017","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.ahjo.2025.100702_bb0415","article-title":"Treatment-Related Coronary Disorders of Fluoropyrimidine Administration: A Systematic Review and Meta-Analysis","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ahjo.2025.100702_bb0420","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0284186X.2019.1711164","article-title":"Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer","volume":"59","author":"Dyhl-Polk","year":"2020","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100702_bb0425","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/annonc\/mdu055","article-title":"Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk","volume":"25","author":"Lestuzzi","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ahjo.2025.100702_bb0430","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2050-6511-15-47","article-title":"A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity","volume":"15","author":"Polk","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0435","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14740330902733961","article-title":"Fluoropyrimidine-associated cardiotoxicity: revisited","volume":"8","author":"Saif","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0440","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1200\/JCO.2005.02.7193","article-title":"Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer","volume":"24","author":"van den Belt-Dusebout","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ahjo.2025.100702_bb0445","doi-asserted-by":"crossref","first-page":"537","DOI":"10.6004\/jnccn.2012.0051","article-title":"Late cardiovascular toxicity following chemotherapy for germ cell tumors","volume":"10","author":"Feldman","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0450","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00380-011-0222-5","article-title":"Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy","volume":"27","author":"Ito","year":"2012","journal-title":"Heart Vessel."},{"issue":"25","key":"10.1016\/j.ahjo.2025.100702_bb0455","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","article-title":"High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis","volume":"29","author":"Moore","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0460","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.ahjo.2025.100702_bb0465","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000300","article-title":"Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease","volume":"8","author":"Lutgens","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ahjo.2025.100702_bb0475","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.21037\/tlcr.2017.12.10","article-title":"Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis","volume":"6","author":"Hu","year":"2017","journal-title":"Transl Lung Cancer Res"},{"issue":"24","key":"10.1016\/j.ahjo.2025.100702_bb0480","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2025.100702_bb0485","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2019.06.021","article-title":"Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study","volume":"120","author":"Bar","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ahjo.2025.100702_bb0490","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.amjms.2018.11.017","article-title":"Hepatotoxicity and Recurrent NSTEMI While on Pembrolizumab for Metastatic Giant Cell Bone Tumor","volume":"357","author":"Kwan","year":"2019","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ahjo.2025.100702_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.107148","article-title":"Immune checkpoint inhibition alters the inflammatory cell composition of human coronary artery atherosclerosis","volume":"43","author":"Newman","year":"2019","journal-title":"Cardiovasc. Pathol."},{"issue":"7","key":"10.1016\/j.ahjo.2025.100702_bb0500","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11912-020-00925-8","article-title":"New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity","volume":"22","author":"Khunger","year":"2020","journal-title":"Curr. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0505","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2014.04.004","article-title":"Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis","volume":"92","author":"Qi","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0510","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ijcard.2013.03.010","article-title":"Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety","volume":"168","author":"Winnik","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2025.100702_bb0515","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vph.2017.10.004","article-title":"Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice","volume":"100","author":"Van der Veken","year":"2018","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100702_bb0520","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14712598.2012.641011","article-title":"Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors","volume":"12","author":"Vuorio","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100702_bb0525","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.ahjo.2025.100702_bb0530","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100702_bb0535","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.seminoncol.2013.01.007","article-title":"Cardiac complications after radical radiotherapy","volume":"40","author":"Martinou","year":"2013","journal-title":"Semin. Oncol."},{"issue":"13","key":"10.1016\/j.ahjo.2025.100702_bb0540","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood-2010-01-263764","article-title":"A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease","volume":"116","author":"Myrehaug","year":"2010","journal-title":"Blood"},{"issue":"9209","key":"10.1016\/j.ahjo.2025.100702_bb0545","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(00)02044-4","article-title":"Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer","volume":"355","author":"Gietema","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahjo.2025.100702_bb0550","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","article-title":"Cardiovascular disease as a long-term complication of treatment for testicular cancer","volume":"21","author":"Huddart","year":"2003","journal-title":"J. Clin. Oncol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602225002058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602225002058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:36:19Z","timestamp":1767990979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602225002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":110,"alternative-id":["S2666602225002058"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2025.100702","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary artery disease and cancer: Shared risk factors, pathogenesis, and treatment effects","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2025.100702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100702"}}